Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer

被引:0
作者
Satoshi Igawa
Shinichiro Ryuge
Tomoya Fukui
Sakiko Otani
Yuka Kimura
Ken Katono
Akira Takakura
Masaru Kubota
Hisashi Mitsufuji
Masato Katagiri
Nobuo Yanase
Noriyuki Masuda
机构
[1] Kitasato University School of Medicine,Department of Respiratory Medicine
[2] Kitasato University,Department of Clinical Physiology, School of Allied Health Sciences
[3] Kitasato University,Department of Nursing
来源
International Journal of Clinical Oncology | 2010年 / 15卷
关键词
Amrubicin; First line; SCLC; Elderly; Poor risk;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:447 / 452
页数:5
相关论文
共 54 条
[1]  
Morita T(2007)A statistical study of lung cancer in the annual of pathological autopsy cases in Japan, from 1958 to 1997, with reference to time trends of lung cancer in the world Jpn J Cancer Res 93 15-23
[2]  
Okamoto H(1999)Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer J Clin Oncol 17 3540-3545
[3]  
Watanabe K(1997)Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy J Natl Cancer Inst 89 577-580
[4]  
Nishiwaki Y(1998)Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer J Clin Oncol 16 3323-3328
[5]  
Souhami RL(2007)Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702 Br J Cancer 97 162-169
[6]  
Spiro SG(1987)Stereospecific total synthesis of 9-aminoanthracyclines: (+)-9-amino-9-deoxydaunomycin and related compounds J Org Chem 52 4477-4485
[7]  
Rudd RM(1998)A new antitumor agent amrubicin induces cell growth inhibition by stabilizing topoisomerase II-DNA complex Jpn J Cancer Res 89 1229-1238
[8]  
Murray N(1998)Cytotoxicity of amrubicin, a novel 9-aminoanthracycline, and its active metabolite amrubicinol on human tumor cells Jpn J Cancer Res 89 1067-1073
[9]  
Grafton C(1989)Antitumor activities of a novel 9-aminoanthracycline (SM-5887) against mouse experimental tumors and human tumor xenografts Jpn J Cancer Res 80 69-76
[10]  
Shah A(1998)Chronic effects of a novel synthetic anthracycline derivative (SM-5887) on normal heart and doxorubicin-induced cardiomyopathy in beagle dogs Investig New Drugs 16 121-128